WHO ICTRP trial
Phase Ia Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics…
ChiCTR2400088540 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400088540 |
|---|---|
| Public title | Phase Ia Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single/Multiple Administration of Increasing Doses of ABP2111Na Tablets in Healthy Subjects in a Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single/Multiple Administration of Increasing Doses of ABP2111Na Tablets |
| Scientific title | Phase Ia Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single/Multiple Administration of Increasing Doses of ABP2111Na Tablets in Healthy Subjects in a Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single/Multiple… |
| Primary sponsor | The First Affiliated Hospital of Bengbu Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Type 2 diabetes |
| Interventions | Experimental group:ABP2111Na tablets administered as a single dose in dose increments of 25mg, 50mg, 100mg, 350mg, 500mg;placebo group:ABP2111Na tablets placebo single administration in dose increments of 25mg, 50mg, 100mg, 350mg… |
| Registration date | Aug 21, 2024 |
| Target size | Experimental group:40;placebo group:10;Food Impact Study Pilot Group:12;Food… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: